Skip to content

Edulcorants Effect in Caries Risk Schoolchildren

Effect of a Daily Dose of Snacks Containing Mannitol or Stevia Rebaudiana as Sweeteners in High Caries Risk Schoolchildren

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03724864
Acronym
STEVIA
Enrollment
271
Registered
2018-10-30
Start date
2017-02-01
Completion date
2018-05-08
Last updated
2018-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

This double-blind RCT aimed to evaluate the effect of sugar-free snacks on caries risk in 6-9 years-old schoolchildren. Considering a 20% difference among groups, the number of subjects needed per group was set in 87. Two-hundred-seventy-one children at risk for caries measured through Cariogram were selected and randomly assigned to three groups consuming twice a day snacks containing Stevia or Maltitol or sugar for 42 days. Parents filled out a standardized questionnaire regarding personal, medical and oral behavioural information. Bleeding on probing, plaque pH and cariogenic microflora were assessed at baseline (t0), after 21 (t1) and 42 days of snacks' use (t2) and 120 days after the end of use (t3). Cariogram was also repeated at t2.

Interventions

DIETARY_SUPPLEMENTdelivery of snacks

Subjects were randomly assigned to three groups (blue, green and yellow), receiving a single type of snack for 42 days. Block randomization ensured similar proportions of participants in each group. All subjects received snack packets (six cookies each) on a weekly basis. Children were instructed to use the snack twice a day, one in the morning and one in the afternoon during lesson breaks. Both participants and investigators were blinded to the treatment assignment.

Sponsors

Università degli Studi di Sassari
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* more than 1 initial carious lesion in the enamel (ICDAS 2-3), * but no manifest lesion in the dentine, * a salivary MS concentration ≥10\^5 CFU/ml.

Exclusion criteria

* Subjects with a history of systemic diseases and antibiotic therapy within 30 days before baseline were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Caries risk reduction42 dayscalculation of the carie risk reduct using a standardised method aka Cariogram
reduction of salivary cariogenic bacteria42 daysreduction of salivary cariogenic bacteria of one level eg from 1000000 to 10000 CFU/ml

Secondary

MeasureTime frameDescription
modification of the plaque-pH42 daysreduction of the Area Under the Curve (AUC) at the critical level of pH of 6.2 and 5.7

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026